GLENMEDE TRUST CO NA - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2020$11,000
+83.3%
100
-10.7%
0.00%
Q2 2020$6,000
-97.6%
112
-96.2%
0.00%
-100.0%
Q1 2020$249,0000.0%2,9690.0%0.00%0.0%
Q4 2019$249,000
+16.9%
2,969
+3.7%
0.00%0.0%
Q3 2019$213,000
+184.0%
2,862
+138.5%
0.00%
Q2 2019$75,0001,2000.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders